Panaceutics
2013
FOUNDED
PRIVATE
STATUS
Series B
LATEST DEAL TYPE
7
INVESTORS
Description
Developer of personalized therapies designed to revolutionize the next generation precision poly therapy dosing and delivery. The company's personalized therapies are fast, safe, accurate and efficient with enhanced CGMP compliance, enabling physicians to treat their patients in an enhanced way.
Website
Formerly Known As
Panacea BioMatx
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Drug Discovery
Primary Office
- P.O. Box 110263
- Research Triangle Park, NC 27709
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Panaceutics’s full profile, request a free trial.
Panaceutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Early Stage VC (Series B) | 01-Jan-2019 | 000.00 | Completed | Startup | ||
| 11. Early Stage VC (Series A) | 00.00 | 000.00 | Completed | Startup | ||
| 10. Early Stage VC | 01-Dec-2016 | 00000 | 00.000 | Completed | Startup | |
| 9. Debt - General | 30-Jun-2016 | 00000 | 00.000 | Completed | Startup | |
| 8. Angel (individual) | 15-Sep-2015 | 000 | 00.000 | Completed | Startup | |
| 7. Early Stage VC | 04-Jun-2015 | 00000 | 00.000 | Completed | Startup | |
| 6. Angel (individual) | 13-May-2015 | 000 | 00.000 | Completed | Startup | |
| 5. Angel (individual) | 01-Mar-2015 | 00000 | 00.000 | 00.00 | Completed | Startup |
| 4. Debt - General | 09-Jun-2014 | $75K | $842K | Completed | Startup | |
| 3. Angel (individual) | 16-Apr-2014 | $267K | $767K | Completed | Startup |
Panaceutics Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 000000000 | 27-Feb-2017 | 000000000000000000 | Pharmaceuticals | 000000 000000 | |
| Next Generation Snacks | 15-Sep-2014 | Merger/Acquisition | Food Products | 000000 000000 |
Panaceutics Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00000000 000000000 | Pharmaceuticals | Cary, NC | 0000 |
Panaceutics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| DSM Venturing | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Alexandria Venture Investments | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| The Launch Place | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| MDO Holdings | Corporation | Minority | 000 0000 | 000000 0 | ||
| Nutrition Capital Network | Corporation | Minority | 000 0000 | 000000 0 |
Panaceutics Executive Team (10)
3 Former Executives
You’re viewing 5 of 10 executives. Get the full list »Panaceutics Board Members (7)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Danny Barnes Ph.D | Panaceutics | Chief Pharmacy Officer & Board Member | 000 0000 | |
| Deon Joubert | Self | Board Member | 000 0000 | |
| Edison Hudson | Panaceutics | Co-Founder, Chief Technology Officer & Board Member | 000 0000 | |
| Mark Montgomery | Panaceutics | Chief Executive Officer & Board Member | 000 0000 | |
| Michael Olander Jr. | Self | Board Member | 000 0000 |